Twist Bioscience (TWST) News Today

Simplify Asset Management Inc. bought a new position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 25,471 shares of the company's stoc

American Century Companies Inc. cut its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 35.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 506,425 shares of the company's sto

William Blair Investment Management LLC cut its stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 9.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,184,386 shares of the company's stock after selling 324,816

Twist Bioscience (NASDAQ:TWST) Shares Up 5.4%

Principal Financial Group Inc. grew its holdings in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 210.2% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 122,911 shares of the company's stock after acquiring an additional 83,287 shares

Twist Bioscience (NASDAQ:TWST) Shares Down 5.6%

Shares of Twist Bioscience Co. (NASDAQ:TWST - Get Free Report) have been assigned an average rating of "Moderate Buy" from the nine analysts that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation and eight have given a buy recommenda

Bank of New York Mellon Corp cut its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 40.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 689,031 shares of the company's stock after selling 466,419

Allspring Global Investments Holdings LLC purchased a new stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 84,205 shares of the company's stoc

Twist Bioscience (NASDAQ:TWST) Trading Down 4.1%

IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 8,153 shares of the company's stock, valued at approximately $402,000. Other he

Twist Bioscience (NASDAQ:TWST) Trading 5.5% Higher

Calamos Advisors LLC acquired a new stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 5,694 shares of the company's stock, valued at approximately $281,000. Oth

Baillie Gifford & Co. reduced its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 19.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 984,302 shares of the company's stock aft

Sumitomo Mitsui Trust Holdings Inc. cut its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 10.9% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,163,431 shares of the company's stock afte

Twist Bioscience (NASDAQ:TWST) Trading Down 4.7%

Shares of Twist Bioscience Co. (NASDAQ:TWST - Get Free Report) have been given an average rating of "Moderate Buy" by the nine analysts that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating and eight have given a buy rating

Barclays dropped their target price on shares of Twist Bioscience from $60.00 to $55.00 and set an "overweight" rating for the company in a research report on Monday.

Twist Bioscience (NASDAQ:TWST - Get Free Report) posted its earnings results on Friday. The company reported ($1.47) EPS for the quarter, missing the consensus estimate of ($0.76) by ($0.71). Twist Bioscience had a negative return on equity of 31.61% and a negative net margin of 69.24%. The business had revenue of $81.50 million for the quarter, compared to analyst estimates of $77.40 million. During the same period in the previous year, the company earned ($1.01) earnings per share. The company's quarterly revenue was up 27.7% compared to the same quarter last year.

Vanguard Group Inc. lessened its position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 0.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,462,232 shares of the company's stock after selling 13,090 shares during th

Silvercrest Asset Management Group LLC boosted its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 38.6% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 134,215 shares of the company's stock after acquiring an additional 37,37

Magnetar Financial LLC bought a new stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 11,345 shares of the company's stock, valued at approximately $

Twist Bioscience (NASDAQ:TWST) Reaches New 12-Month High at $59.60

Sei Investments Co. raised its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 32.7% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 223,555 shares of the company's stock after b

Lord Abbett & CO. LLC increased its position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 40.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 301,495 shares of the company's stock after ac

SageView Advisory Group LLC bought a new position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 33,332 shares of the company's stock, valued at approxima

Susquehanna Fundamental Investments LLC purchased a new position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 8,736 shares of the company's stock, valued at a

Shares of Twist Bioscience Co. (NASDAQ:TWST - Get Free Report) have earned an average rating of "Buy" from the eight ratings firms that are currently covering the company, Marketbeat.com reports. Eight investment analysts have rated the stock with a buy rating. The average 12 month target price am